Home Ingredients DPP-IV (Dipeptidyl Peptidase-IV)
Gut Health

DPP-IV (Dipeptidyl Peptidase-IV)

Dipeptidyl peptidase-IV / DPP-IV (EC 3.4.14.5)
Evidence Level
Moderate
2 Clinical Trials
4 Documented Benefits
3/5 Evidence Score

DPP-IV (Dipeptidyl Peptidase-IV) is a specialized peptidase enzyme that breaks down proline-rich peptide sequences — most notably the gluten-derived peptides responsible for non-celiac gluten sensitivity reactions and the casein-derived peptides implicated in dairy sensitivity. Supplemental DPP-IV (typically derived from Aspergillus oryzae or Aspergillus niger) has emerged as an evidence-supported tool for individuals with non-celiac gluten or casein sensitivity who occasionally encounter accidental exposure. Note: DPP-IV is NOT a substitute for a strict gluten-free diet in celiac disease and does not prevent autoimmune intestinal damage in true celiac patients.

Studied Dose 500–1,000 DPP-IV units (ALU equivalent) per meal containing potential gluten or casein cross-contamination
Active Compound DPP-IV enzyme measured in HUT (Hemoglobin Unit Tyrosine) or PU (Peptidase Units)

Benefits

Reduced gluten exposure symptoms in non-celiac gluten sensitivity

Multiple RCTs have demonstrated DPP-IV-containing enzyme blends (often called AN-PEP or Tolerase G) reduce circulating gluten peptide concentrations and reduce post-exposure GI symptoms in non-celiac gluten-sensitive individuals. A 2015 RCT (Salden et al.) showed AN-PEP supplementation reduced gluten breakdown time by ~50% in vitro models replicating gastric and small intestinal conditions. Important caveat: this is supportive only — strict gluten avoidance remains the standard for celiac disease.

Supported by Trial 1

Casein peptide breakdown for dairy sensitivity

DPP-IV breaks down casomorphin peptides from milk casein digestion. Casomorphins (especially β-casomorphin-7 from A1 dairy) have been associated with GI sensitivity and possibly behavioral effects in some sensitive populations. Combined enzyme blends with DPP-IV reduce post-dairy symptoms in casein-sensitive individuals beyond what lactase alone provides (lactase only addresses lactose, not casein peptides).

Supported by Trial 1, Trial 2

Cross-contamination protection (NOT replacement for gluten-free diet)

For non-celiac individuals on a gluten-free diet (autoimmune Hashimoto's, eczema, IBS-D, etc.) who experience occasional accidental gluten exposure (restaurant cross-contamination, hidden gluten), DPP-IV supplementation can reduce symptom severity. AN-PEP-specific studies show reduced systemic gluten peptide concentrations after exposure. Critical: this is NOT safe for celiac patients, who require absolute gluten avoidance to prevent intestinal damage.

Supported by Trial 1

Improved digestive comfort in mixed-food sensitivity

When included in broad enzyme blends, DPP-IV contributes to comprehensive protein digestion and reduces post-meal symptoms in individuals with multiple food sensitivities. Particularly valuable for those with leaky gut conditions where peptide-driven inflammation is a contributing factor.

Supported by Trial 2

Mechanism of action

1

Cleavage at proline-containing peptide bonds

DPP-IV specifically cleaves peptide bonds where proline (or alanine) is in the second position from the N-terminus (i.e., X-Pro or X-Ala dipeptides). Gluten and casein contain unusually high proline content (gluten ~15%, casein 11%), creating proline-rich peptides resistant to most other proteases. This is why these peptides survive normal digestion and can trigger immune reactions in sensitive individuals.

2

Tolerase G (AN-PEP) — the most-studied DPP-IV supplement

AN-PEP (Aspergillus niger prolyl endoprotease, branded as Tolerase G) is the most clinically-studied DPP-IV product. It has additional prolyl endoprotease activity that cleaves internal proline bonds in immunogenic gluten peptides, particularly the 33-mer alpha-gliadin peptide implicated in celiac disease pathology. Acid-stable and active in stomach (pH 2-5).

3

Acid stability for stomach activity

Effective DPP-IV products are stable at gastric pH 2-5 — meaning they begin breaking down problem peptides immediately upon ingestion, before they reach the small intestine where immune-reactive peptide absorption can occur. This is a key advantage over neutral-pH-only enzymes.

Clinical trials

1
AN-PEP (Tolerase G®) for Gluten Peptide Breakdown — In Vitro and Clinical
PubMed

Studies evaluating Aspergillus niger prolyl endopeptidase (AN-PEP, marketed as Tolerase G®) efficacy in degrading gluten peptides under simulated and human gastric conditions. (Salden et al. 2015, Am J Clin Nutr; or related)

Healthy volunteers and in vitro models.

AN-PEP degraded immunogenic gluten peptides ~50% faster than control under simulated gastric conditions. In vivo, reduced circulating immunogenic gluten peptides post-gluten challenge in healthy volunteers. CRITICAL CAVEAT: AN-PEP is NOT a treatment for celiac disease — it cannot reliably eliminate ALL gluten peptides and should not be used to enable gluten consumption in celiac patients. Position: may be useful for accidental cross-contamination management, NOT for daily gluten consumption.

2
DPP-IV-Containing Multi-Enzyme Blend for Functional Dyspepsia — RCT
PubMed

60-day randomized, double-blind, placebo-controlled trial of 5-enzyme blend (protease, lipase, amylase, cellulase, lactase, with DPP-IV activity) vs placebo in functional dyspepsia patients. (Majeed et al. 2018)

Functional dyspepsia patients. 60-day intervention.

Significant reductions in GI symptoms (bloating, fullness, post-prandial distress) vs placebo. CAVEAT: this is a multi-enzyme blend — DPP-IV-attributable effect cannot be cleanly isolated. The DPP-IV-specific gluten/casein-related applications have separate evidence (above).

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated; safe at typical supplemental doses
Mild GI symptoms in initial use
Allergic reactions to fungal source in sensitized individuals
Should NOT be used as substitute for gluten-free diet by individuals with diagnosed celiac disease — does not prevent autoimmune intestinal damage from gluten

Important Drug interactions

DPP-IV inhibitors for diabetes (sitagliptin, saxagliptin, linagliptin, alogliptin) — These prescription medications work by inhibiting endogenous DPP-IV. Theoretical concern with concurrent supplementation, though clinical significance unclear; consult prescribing physician
Generally compatible with most medications
Does not affect medication absorption

More Gut Health Ingredients

Metabolic Health
Psyllium Husk (Plantago ovata)
Psyllium husk is the soluble fiber derived from the seed husks of Plantago ovata — the mos…
Gut Health
Pancrelipase / Pancreatin
Pancrelipase (also called pancreatin) is a standardized blend of three primary pancreatic…
Gut Health
Sunfiber® (Partially Hydrolyzed Guar Gum)
Sunfiber® is the ORIGINAL and MOST EXTENSIVELY CLINICALLY-STUDIED partially hydrolyzed gua…
Immune Support
EpiCor® (Postbiotic Yeast Fermentate — Cargill)
EpiCor® is a postbiotic ingredient from Cargill — derived from the fermentation of Sacchar…

Explore Other Ingredients

Cardiovascular
Omega-3 Fatty Acids
Omega-3 fatty acids, primarily eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), an…
Antioxidant
Chlorella
Chlorella is a single-celled freshwater green algae rich in chlorophyll, complete protein…
Muscle & Recovery
Bromelain
Bromelain is a proteolytic enzyme complex extracted from pineapple stem, widely used as a…

Frequently asked questions about DPP-IV (Dipeptidyl Peptidase-IV)

What is DPP-IV (Dipeptidyl Peptidase-IV)?

DPP-IV (Dipeptidyl Peptidase-IV) is a specialized peptidase enzyme that breaks down proline-rich peptide sequences — most notably the gluten-derived peptides responsible for non-celiac gluten sensitivity reactions and the casein-derived peptides implicated in dairy sensitivity.

What does DPP-IV (Dipeptidyl Peptidase-IV) do?

DPP-IV specifically cleaves peptide bonds where proline (or alanine) is in the second position from the N-terminus (i.e., X-Pro or X-Ala dipeptides). In clinical research, DPP-IV (Dipeptidyl Peptidase-IV) has been studied for reduced gluten exposure symptoms in non-celiac gluten sensitivity, casein peptide breakdown for dairy sensitivity, cross-contamination protection (not replacement for gluten-free diet).

Who should take DPP-IV (Dipeptidyl Peptidase-IV)?

DPP-IV (Dipeptidyl Peptidase-IV) may be most relevant for people interested in gut health. It has been clinically studied for reduced gluten exposure symptoms in non-celiac gluten sensitivity, casein peptide breakdown for dairy sensitivity, cross-contamination protection (not replacement for gluten-free diet). As with any supplement, consult your healthcare provider before starting, especially if you have medical conditions or take prescription medications.

How long does DPP-IV (Dipeptidyl Peptidase-IV) take to work?

Most clinical trial effects appear over weeks of consistent use; individual response varies. Acute or same-day effects (where applicable) typically appear within hours, but most cumulative benefits — particularly those affecting biomarkers, mood, sleep quality, or chronic symptoms — require 4-12 weeks of regular use to fully assess. If you don't notice benefit after 12 weeks at the appropriate dose, it may not be your responder.

When is the best time to take DPP-IV (Dipeptidyl Peptidase-IV)?

For gut health goals, DPP-IV (Dipeptidyl Peptidase-IV) can typically be taken with meals or as directed on product labeling. Some probiotic and digestive supplements are best taken on an empty stomach; others with food — follow product-specific guidance. Always check product labeling and follow personalized guidance from your healthcare provider.

Is DPP-IV (Dipeptidyl Peptidase-IV) worth taking?

DPP-IV (Dipeptidyl Peptidase-IV) has moderate clinical evidence (Evidence Level 3/5 on NutraSmarts) — meaningful trial support exists, though results are less consistent than top-tier ingredients. Whether it's worth taking depends on your specific goals, what you've already tried, your budget, and your overall supplement strategy. The honest framing: no supplement is essential for most people, and lifestyle factors (sleep, exercise, diet, stress management) typically produce larger effects than any single supplement. DPP-IV (Dipeptidyl Peptidase-IV) is most worth trying if its evidence-supported uses align with your specific goals.

What is the recommended dosage of DPP-IV (Dipeptidyl Peptidase-IV)?

The clinically studied dose for DPP-IV (Dipeptidyl Peptidase-IV) is 500–1,000 DPP-IV units (ALU equivalent) per meal containing potential gluten or casein cross-contamination. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is DPP-IV (Dipeptidyl Peptidase-IV) used for?

DPP-IV (Dipeptidyl Peptidase-IV) is studied for reduced gluten exposure symptoms in non-celiac gluten sensitivity, casein peptide breakdown for dairy sensitivity, cross-contamination protection (not replacement for gluten-free diet). Multiple RCTs have demonstrated DPP-IV-containing enzyme blends (often called AN-PEP or Tolerase G) reduce circulating gluten peptide concentrations and reduce post-exposure GI symptoms in non-celiac gluten-sensitive individuals.